
FOXO4-DRI· 10mg
FOXO4-derived senolytic peptide (Proxofim)
Vendor VerdictScore
Our Rating — VialVerdict's internal supplier score until more customer reviews are available.
Product + vendor context
FOXO4-DRI from Ascension
This page covers FOXO4-DRI as sold by Ascension. Product-specific reviews are only counted when a reviewer selects this exact vendor/product pair. Vendor reviews, external review signals, and the vendor VerdictScore are shown separately so broad vendor reputation does not masquerade as product-specific proof.
Detailed mechanism and research notes for this peptide are still being compiled. Check back shortly — or browse vendor reviews below to see real buyer experiences.
Current catalogue snapshot: 10mg vial, $220.00 total, $22.00/mg, listed in stock. VialVerdict records 98.5% purity for this row.
Frequently asked questions about Ascension FOXO4-DRI
Is Ascension FOXO4-DRI reviewed separately from vendor reviews?
What does VialVerdict know about this FOXO4-DRI listing?
Why show vendor reviews on a FOXO4-DRI product page?
Does VialVerdict earn from Ascension links?
Vendor-level reviews for Ascension
These reviews describe the vendor overall — shipping, packaging, support, and fulfilment — not necessarily this exact FOXO4-DRI listing.